List of Tables
Table 1. Global Cell-based Flu Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cell-based Flu Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cell-based Flu Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cell-based Flu Vaccine Sales (M Doses) of Key Manufacturers (2020-2025)
Table 5. Global Cell-based Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cell-based Flu Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cell-based Flu Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cell-based Flu Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cell-based Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cell-based Flu Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cell-based Flu Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Cell-based Flu Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cell-based Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-based Flu Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cell-based Flu Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cell-based Flu Vaccine Sales by Region (2020-2025) & (M Doses)
Table 18. Global Cell-based Flu Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Cell-based Flu Vaccine Sales by Region (2026-2031) & (M Doses)
Table 20. Global Cell-based Flu Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Cell-based Flu Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cell-based Flu Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Cell-based Flu Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cell-based Flu Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Cell-based Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cell-based Flu Vaccine Sales by Country (2020-2025) & (M Doses)
Table 27. North America Cell-based Flu Vaccine Sales by Country (2026-2031) & (M Doses)
Table 28. North America Cell-based Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cell-based Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cell-based Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cell-based Flu Vaccine Sales by Country (2020-2025) & (M Doses)
Table 32. Europe Cell-based Flu Vaccine Sales by Country (2026-2031) & (M Doses)
Table 33. Europe Cell-based Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cell-based Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cell-based Flu Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cell-based Flu Vaccine Sales by Region (2020-2025) & (M Doses)
Table 37. Asia Pacific Cell-based Flu Vaccine Sales by Region (2026-2031) & (M Doses)
Table 38. Asia Pacific Cell-based Flu Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cell-based Flu Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cell-based Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cell-based Flu Vaccine Sales by Country (2020-2025) & (M Doses)
Table 42. Latin America Cell-based Flu Vaccine Sales by Country (2026-2031) & (M Doses)
Table 43. Latin America Cell-based Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cell-based Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cell-based Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cell-based Flu Vaccine Sales by Country (2020-2025) & (M Doses)
Table 47. Middle East and Africa Cell-based Flu Vaccine Sales by Country (2026-2031) & (M Doses)
Table 48. Middle East and Africa Cell-based Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cell-based Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cell-based Flu Vaccine Sales (M Doses) by Type (2020-2025)
Table 51. Global Cell-based Flu Vaccine Sales (M Doses) by Type (2026-2031)
Table 52. Global Cell-based Flu Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Cell-based Flu Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Cell-based Flu Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cell-based Flu Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cell-based Flu Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Cell-based Flu Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Cell-based Flu Vaccine Price (US$/Dose) by Type (2020-2025)
Table 59. Global Cell-based Flu Vaccine Price (US$/Dose) by Type (2026-2031)
Table 60. Global Cell-based Flu Vaccine Sales (M Doses) by Application (2020-2025)
Table 61. Global Cell-based Flu Vaccine Sales (M Doses) by Application (2026-2031)
Table 62. Global Cell-based Flu Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Cell-based Flu Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Cell-based Flu Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cell-based Flu Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cell-based Flu Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Cell-based Flu Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Cell-based Flu Vaccine Price (US$/Dose) by Application (2020-2025)
Table 69. Global Cell-based Flu Vaccine Price (US$/Dose) by Application (2026-2031)
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. GlaxoSmithKline Cell-based Flu Vaccine Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Sanofi Cell-based Flu Vaccine Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Pfizer Cell-based Flu Vaccine Product
Table 84. Pfizer Recent Developments/Updates
Table 85. MedImmune, LLC Company Information
Table 86. MedImmune, LLC Description and Business Overview
Table 87. MedImmune, LLC Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. MedImmune, LLC Cell-based Flu Vaccine Product
Table 89. MedImmune, LLC Recent Developments/Updates
Table 90. Intravacc Company Information
Table 91. Intravacc Description and Business Overview
Table 92. Intravacc Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Intravacc Cell-based Flu Vaccine Product
Table 94. Intravacc Recent Developments/Updates
Table 95. CSL Limited Company Information
Table 96. CSL Limited Description and Business Overview
Table 97. CSL Limited Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. CSL Limited Cell-based Flu Vaccine Product
Table 99. CSL Limited Recent Developments/Updates
Table 100. E. Merck KG Company Information
Table 101. E. Merck KG Description and Business Overview
Table 102. E. Merck KG Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. E. Merck KG Cell-based Flu Vaccine Product
Table 104. E. Merck KG Recent Developments/Updates
Table 105. Novartis Company Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Novartis Cell-based Flu Vaccine Product
Table 109. Novartis Recent Developments/Updates
Table 110. Danaher Corporation Company Information
Table 111. Danaher Corporation Description and Business Overview
Table 112. Danaher Corporation Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Danaher Corporation Cell-based Flu Vaccine Product
Table 114. Danaher Corporation Recent Developments/Updates
Table 115. SINOVAC Company Information
Table 116. SINOVAC Description and Business Overview
Table 117. SINOVAC Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. SINOVAC Cell-based Flu Vaccine Product
Table 119. SINOVAC Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Cell-based Flu Vaccine Distributors List
Table 123. Cell-based Flu Vaccine Customers List
Table 124. Cell-based Flu Vaccine Market Trends
Table 125. Cell-based Flu Vaccine Market Drivers
Table 126. Cell-based Flu Vaccine Market Challenges
Table 127. Cell-based Flu Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cell-based Flu Vaccine
Figure 2. Global Cell-based Flu Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell-based Flu Vaccine Market Share by Type: 2024 & 2031
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Cell-based Flu Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Cell-based Flu Vaccine Market Share by Application: 2024 & 2031
Figure 8. Aldults
Figure 9. Children
Figure 10. Global Cell-based Flu Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Cell-based Flu Vaccine Market Size (2020-2031) & (US$ Million)
Figure 12. Global Cell-based Flu Vaccine Sales (2020-2031) & (M Doses)
Figure 13. Global Cell-based Flu Vaccine Average Price (US$/Dose) & (2020-2031)
Figure 14. Cell-based Flu Vaccine Report Years Considered
Figure 15. Cell-based Flu Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global Cell-based Flu Vaccine Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Cell-based Flu Vaccine Players: Market Share by Revenue in Cell-based Flu Vaccine in 2024
Figure 18. Cell-based Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Cell-based Flu Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Cell-based Flu Vaccine Sales Market Share by Country (2020-2031)
Figure 21. North America Cell-based Flu Vaccine Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Cell-based Flu Vaccine Sales Market Share by Country (2020-2031)
Figure 25. Europe Cell-based Flu Vaccine Revenue Market Share by Country (2020-2031)
Figure 26. Germany Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Cell-based Flu Vaccine Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Cell-based Flu Vaccine Revenue Market Share by Region (2020-2031)
Figure 33. China Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Cell-based Flu Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Cell-based Flu Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Cell-based Flu Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Cell-based Flu Vaccine Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. U.A.E Cell-based Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Cell-based Flu Vaccine by Type (2020-2031)
Figure 54. Global Revenue Market Share of Cell-based Flu Vaccine by Type (2020-2031)
Figure 55. Global Cell-based Flu Vaccine Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of Cell-based Flu Vaccine by Application (2020-2031)
Figure 57. Global Revenue Market Share of Cell-based Flu Vaccine by Application (2020-2031)
Figure 58. Global Cell-based Flu Vaccine Price (US$/Dose) by Application (2020-2031)
Figure 59. Cell-based Flu Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
